학술논문
PSMAddition: A phase 3 trial to compare treatment with Lu-177-PSMA-617 plus standard of care (SOC) versus SOC alone in patients with metastatic hormone-sensitive prostate cancer.
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15277755